
원본
Thermo Fisher Scientific ALPK3 Monoclonal Antibody (4G4)
상품 한눈에 보기
인간 ALPK3 단백질을 인식하는 Mouse monoclonal 항체. Western blot, IHC, ICC/IF, ELISA 등 다양한 응용에 사용 가능. 친화 크로마토그래피로 정제된 액상 형태. 보존제 무첨가, -20°C에서 보관 권장.
- 카탈로그번호
- H00057538-M01
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 04. 오후 12:13
카탈로그 번호 · 상품 설명출고판매가담기
Thermo Fisher Scientific H00057538-M01 ALPK3 Monoclonal Antibody (4G4) 100 ug pk판매 단위 pk ·
재고 확인 필요
518,100원VAT 포함 569,910원
Thermo Fisher Scientific · Thermo Fisher Scientific ALPK3 Monoclonal Antibody (4G4)
Applications and Tested Dilution
| Application | Tested Dilution |
|---|---|
| Western Blot (WB) | 1–5 µg/mL |
| Immunohistochemistry (Paraffin) (IHC (P)) | 1 µg/mL |
| Immunocytochemistry (ICC/IF) | 10 µg/mL |
| ELISA | 10 µg/mL |
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human |
| Host / Isotype | Mouse / IgG1, kappa |
| Class | Monoclonal |
| Type | Antibody |
| Clone | 4G4 |
| Immunogen | ALPK3 (NP_065829, 1811–1906 a.a.) partial recombinant protein with GST tag (GST tag MW: 26 kDa) |
| Conjugate | Unconjugated |
| Form | Liquid |
| Concentration | See Label |
| Purification | Affinity chromatography |
| Storage Buffer | PBS, pH 7.4 |
| Contains | No preservative |
| Storage Conditions | -20°C, Avoid Freeze/Thaw Cycles |
| Shipping Conditions | Ambient (domestic); Wet ice (international) |
Product Specific Information
Sequence of this protein is as follows:
SSHQCNAYCE LLGLTPLKGP EAAHPQAKAK GSKSPSAGRK GSQLSPQPQK KGLPSPQGTR KSAPSSKATP QASEPVTTQL LGQPPTQEEG SKAQGM
Target Information
Predicted to enable ATP binding activity, protein serine kinase activity, and protein serine/threonine kinase activity.
Involved in cardiac muscle cell development and predicted to be active in the nucleus.
Implicated in hypertrophic cardiomyopathy.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.
